Condition
Optic Nerve Disease
Total Trials
4
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 1 (1)
Trial Status
Recruiting1
Enrolling By Invitation1
Not Yet Recruiting1
Unknown1
Clinical Trials (4)
Showing 4 of 4 trials
NCT04607369Enrolling By InvitationPrimary
Implementation of the NEDS EyeCTester App
NCT07258667Phase 1Not Yet Recruiting
Pilot Study of the Efficacy of Nicotinamide (Vitamin B3) in Leber's Hereditary Optic Neuropathy
NCT03011541Not ApplicableRecruiting
Stem Cell Ophthalmology Treatment Study II
NCT01920867Not ApplicableUnknown
Stem Cell Ophthalmology Treatment Study
Showing all 4 trials